Arcutis Biotherapeutics Achieves Record Revenue Growth and Profit
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) has reached a record high following an impressive financial performance in the third quarter of 2023. The biotechnology company reported a significant turnaround, swinging to a…